Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. MRNA
10. KNX

Go back to Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2019 Financial Results

Goldman Sachs Downgrades Calyxt Inc. (CLXT) to Neutral Following Q4 EPS

March 5, 2020 7:15 PM EST

Goldman Sachs analyst Adam Samuelson downgraded Calyxt Inc. (NASDAQ: CLXT) from Buy to Neutral with a price target of $7.00 (from $19.00).

For an analyst ratings summary and ratings history on Calyxt Inc. click here. For more ratings news on Calyxt Inc. click here.

Shares of Calyxt Inc. closed at $6.56 yesterday.

... More

Cellectis (CLLS) Tops Q4 EPS by 19c

March 4, 2020 4:33 PM EST

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.54), $0.19 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $3.08 million versus the consensus estimate of $4.95 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

... More